NDC 62856-001

Hexalen

Altretamine

Hexalen is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Altretamine.

Product ID62856-001_0a2ea556-16ca-4275-81e0-d721477f047b
NDC62856-001
Product TypeHuman Prescription Drug
Proprietary NameHexalen
Generic NameAltretamine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1990-12-26
Marketing CategoryNDA / NDA
Application NumberNDA019926
Labeler NameEisai Inc.
Substance NameALTRETAMINE
Active Ingredient Strength50 mg/1
Pharm ClassesAlkylating Activity [MoA],Alkylating Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 62856-001-10

100 CAPSULE in 1 BOTTLE (62856-001-10)
Marketing Start Date1990-12-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62856-001-10 [62856000110]

Hexalen CAPSULE
Marketing CategoryNDA
Application NumberNDA019926
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1990-12-26
Marketing End Date2019-12-31

Drug Details

Active Ingredients

IngredientStrength
ALTRETAMINE50 mg/1

OpenFDA Data

SPL SET ID:8456a8db-a7f6-4bc0-86be-e9c8c374140b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197323
  • 153473
  • UPC Code
  • 0362856001106
  • Pharmacological Class

    • Alkylating Activity [MoA]
    • Alkylating Drug [EPC]

    Trademark Results [Hexalen]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    HEXALEN
    HEXALEN
    78079606 2872488 Live/Registered
    EISAI INC.
    2001-08-16
    HEXALEN
    HEXALEN
    73761079 1540083 Live/Registered
    U.S. BIOSCIENCE, INC.
    1988-10-31

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.